Aspirin (DL-lysine)

Aspirin DL-lysine (ASA DL-lysine) is a lysine-containing aspirin derivative. Aspirin DL-lysine inhibits cyclooxygenase (COX) in platelets, blocks the synthesis of thromboxane A2 (TXA2), and thus inhibits platelet aggregation and activation. Aspirin DL-lysine can be used to study thrombin generation in patients with unstable angina pectoris[1].

Product Specifications

CAS Number

[62952-06-1]

Product Name Alternative

Acetylsalicylic acid (DL-lysine) ; ASA (DL-lysine)

UNSPSC

12352005

Hazard Statement

H302

Target

COX; NF-κB; p38 MAPK

Type

Reference compound

Related Pathways

Immunology/Inflammation; MAPK/ERK Pathway; NF-κB

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology; Cardiovascular Disease; Others

Assay Protocol

https://www.medchemexpress.com/aspirin-dl-lysine.html

Smiles

O=C(C1=C(OC(C)=O)C=CC=C1)O.O=C(C(CCCCN)N)O

Molecular Formula

C15H22N2O6

Molecular Weight

326.34

Precautions

P264-P270-P330-P501

References & Citations

[1]Yasu T, et al. Effects of aspirin DL-lysine on thrombin generation in unstable angina pectoris[J]. The American journal of cardiology, 1993, 71 (13) : 1164-1168.